company background image
IJF logo

ICON DB:IJF Stock Report

Last Price

€196.10

Market Cap

€16.3b

7D

-2.2%

1Y

-23.1%

Updated

19 Dec, 2024

Data

Company Financials +

ICON Public Limited Company

DB:IJF Stock Report

Market Cap: €16.3b

IJF Stock Overview

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. More details

IJF fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance5/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

ICON Public Limited Company Competitors

Price History & Performance

Summary of share price highs, lows and changes for ICON
Historical stock prices
Current Share PriceUS$196.10
52 Week HighUS$316.30
52 Week LowUS$174.85
Beta1.2
1 Month Change7.72%
3 Month Change-26.72%
1 Year Change-23.10%
3 Year Change-28.43%
5 Year Change28.17%
Change since IPO2,364.34%

Recent News & Updates

Recent updates

Shareholder Returns

IJFDE Life SciencesDE Market
7D-2.2%-4.2%-2.6%
1Y-23.1%-5.3%7.1%

Return vs Industry: IJF underperformed the German Life Sciences industry which returned -3.9% over the past year.

Return vs Market: IJF underperformed the German Market which returned 8% over the past year.

Price Volatility

Is IJF's price volatile compared to industry and market?
IJF volatility
IJF Average Weekly Movement7.1%
Life Sciences Industry Average Movement7.2%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.6%
10% least volatile stocks in DE Market2.5%

Stable Share Price: IJF's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: IJF's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
199042,250Steve Cutlerwww.iconplc.com

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization.

ICON Public Limited Company Fundamentals Summary

How do ICON's earnings and revenue compare to its market cap?
IJF fundamental statistics
Market cap€16.28b
Earnings (TTM)€721.72m
Revenue (TTM)€8.02b

22.6x

P/E Ratio

2.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IJF income statement (TTM)
RevenueUS$8.31b
Cost of RevenueUS$5.85b
Gross ProfitUS$2.46b
Other ExpensesUS$1.71b
EarningsUS$747.89m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)9.06
Gross Margin29.64%
Net Profit Margin9.00%
Debt/Equity Ratio35.1%

How did IJF perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 17:39
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ICON Public Limited Company is covered by 45 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Armelle MoulinAlphaValue
Gregory BolanAvondale Partners
Eric ColdwellBaird